Treace Medical ConceptsTMCI +7.75%67 PB Ratio is 3.73 as of Jun. 25, 2026, which is 33% below its 10-year median of 5.57. GuruFocus rates TMCI with a GF Score™ of 67/100 and a GF Value™ of $6.87 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Treace Medical Concepts ranks worse than 69.16% on this metric.
The historical rank and industry rank for Treace Medical Concepts's PB Ratio or its related term are showing as below:
TMCI'
s PB Ratio Range Over the Past 10 Years
Min: 0.89 Med: 5.57 Max: 23.84
Current: 3.74
During the past 7 years, Treace Medical Concepts's highest PB Ratio was 23.84. The lowest was 0.89. And the median was 5.57.
TMCI's PB Ratio is ranked worse than 69.16% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs TMCI: 3.74
During the past 12 months, Treace Medical Concepts's average Book Value Per Share Growth Rate was -28.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 7.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Treace Medical Concepts was 7.90% per year. The lowest was 1.80% per year. And the median was 4.85% per year.
Back to Basics: PB Ratio
Treace Medical Concepts (NAS:TMCI) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Treace Medical Concepts's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Treace Medical Concepts PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Treace Medical Concepts's PB Ratio distribution charts can be found below:
* The bar in red indicates where Treace Medical Concepts's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Treace Medical Concepts (TMCI) has a PB Ratio of 3.73 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Treace Medical Concepts and its competitors. This is 33% below median its historical median of 5.57. Over the past decade, Treace Medical Concepts' PB Ratio has ranged from 0.89 to 23.84. According to the industry distribution chart, Treace Medical Concepts ranks #545 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 69.2%.
Is Treace Medical Concepts' PB Ratio too high?
Treace Medical Concepts' current PB Ratio of 3.73 is 33% below median its 10-year median of 5.57. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 23.84. The Medical Devices & Instruments industry median PB Ratio is 2.05. Treace Medical Concepts' value of 3.73 is 82.4% above this industry median. Based on the distribution chart, Treace Medical Concepts ranks #545 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Treace Medical Concepts has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Treace Medical Concepts' PB Ratio compare to RXST and TLSI?
According to the Medical Devices & Instruments industry distribution chart, Treace Medical Concepts ranks #545 out of 788 companies for PB Ratio. This places Treace Medical Concepts in the lower half of its industry. The industry median PB Ratio is 2.05. Treace Medical Concepts' value of 3.73 is 82.4% above this benchmark. Historically, Treace Medical Concepts' own PB Ratio has ranged from 0.89 to 23.84 over the past decade. While the company's 10-year median is 5.57 vs. the industry median of 2.05, Treace Medical Concepts has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Treace Medical Concepts's current PB Ratio of 3.73 is 82.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Treace Medical Concepts and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Treace Medical Concepts's current PB Ratio is 3.73, which is 33% below median its own 10-year median of 5.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Treace Medical Concepts stock overvalued right now?
Based on GuruFocus' analysis, Treace Medical Concepts (TMCI) is currently considered Possible Value Trap. The stock's GF Value™ is $6.87, compared to a current price of $4.45 — trading 35.3% below its estimated fair value. The current PB Ratio is 3.73, which is 33% below median its 10-year median of 5.57 and 82.4% above the Medical Devices & Instruments industry median of 2.05. Treace Medical Concepts' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Treace Medical Concepts (TMCI), the current PB Ratio is 3.73 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Treace Medical Concepts (TMCI) Overvalued in 2026?
Based on GuruFocus' analysis, Treace Medical Concepts stock appears to be undervalued.
The current stock price of $4.45 is trading 35.3% below its estimated GF Value™ of $6.87.
GuruFocus considers Treace Medical Concepts to be Possible Value Trap.
Key valuation signals for TMCI:
PB Ratio: 3.73 (33% below median its 10-year median of 5.57)
GF Value™: $6.87 vs. price of $4.45 (35.3% below fair value)
Industry Position: 82.4% above the Medical Devices & Instruments median (#545 of 788)
No single metric tells the full story. See the TMCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
67GF Score
Get the complete analysis for TMCI
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TMCI has been successfully added to your 
